Global Autoinjectors Market 2018-2030

Dublin, June 26, 2018 (GLOBE NEWSWIRE) -- The "Global Autoinjectors Market (2nd Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering.

The Global Autoinjectors Market (2nd Edition), 2018-2030' report provides a comprehensive analysis of the current state of the autoinjectors market and the likely future evolution of these devices over the next decade. The study presents an in-depth analysis of a diverse set of companies that are engaged in this domain across different regions of the globe.

Over the years, the self-injection devices market has grown into a promising segment of the pharmaceutical industry. The domain is presently characterized by the presence of advanced technology platforms and innovative devices, offering a variety of user-friendly drug delivery solutions.

One of the major driving forces behind the growth in this field is the rising incidence of chronic clinical conditions, such as rheumatoid arthritis, multiple sclerosis and diabetes. Although various pharmacological interventions are available for the treatment of these conditions, they require parenteral administration, frequent hospital visits, and are associated with multiple concerns, such as dosing and medication errors, risk of microbial contamination and needlestick injuries.

However, therapies developed in combination with self-administration enabling devices have witnessed high adoption rates and have actually resulted in marked improvements in adherence to prescribed therapeutic regimens. In addition, such devices have been widely utilized in the treatment of emergency conditions such as anaphylaxis and other allergic disorders.

Amongst other elements, the report includes:

Key Topics Covered:

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Drug Delivery Systems
3.3. Conventional Parenteral Delivery
3.4. Needlestick Injuries
3.5. Self-Administration: An Emerging Trend
3.6. Safety Options in Self-Injectors
3.7 Types of Self-Injection Devices
3.8. Autoinjectors: An Important Class of Self-Injection Devices
3.9. Concluding Remarks

4. PRIMARY DRUG CONTAINERS IN AUTOINJECTORS
4.1. Chapter Overview
4.2. Introduction to Primary Drug Containers
4.3 Types of Primary Drug Containers

5. AUTOINJECTORS: CURRENT MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Autoinjectors: Overall Market Overview
5.3. Approved Combination Products: Overall Market Overview
5.4. Pipeline Combination Products: Overall Market Overview

6. PATENT ANALYSIS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Autoinjectors: Patent Analysis
6.4. Autoinjectors: Patent Benchmarking Analysis
6.5. Autoinjectors: Patent Valuation Analysis
6.6. Leading Patents Based on Number of Citations

7. CASE STUDIES
7.1. Chapter Overview
7.2. Marketed / Pipeline Drugs Being Evaluated with Autoinjectors
7.3 Case Study I: Anaphylaxis
7.4. Case Study II: Multiple Sclerosis
7.5. Case Study III: Migraine
7.6. Case Study IV: Rheumatoid Arthritis

8. LIKELY DRUG CANDIDATES FOR DELIVERY VIA AUTOINJECTORS
8.1. Chapter Overview
8.2. Marketed Molecules
8.3. Pipeline Molecules

9. KEY PLAYERS
9.1. Chapter Overview
9.2. Antares Pharma
9.3. Company Overview
9.4. DALI Medical Devices
9.5. Elcam Medical (E3D Elcam Drug Delivery Devices)
9.6. Jiangsu Delfu Medical Devices
9.7. Meridian Medical Technologies
9.8. Owen Mumford
9.9. SHL Group
9.10. Union Medico
9.11. Ypsomed

10. EMERGING PLAYERS
10.1. Chapter Overview
10.2. AktiVax
10.3. Future Injection Technologies
10.4. Impax Laboratories (Amedra Pharmaceuticals)
10.5. Kalo Pharma
10.6. MiniEpi
10.7. Nemera
10.8. Nuance Designs
10.9. Oval Medical Technologies
10.10. Windgap Medical
10.11. Xeris Pharmaceuticals
10.12. Zion Clinical Pharmacy

11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats

12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Global Autoinjectors Market
12.3. Autoinjectors Market for Anaphylaxis
12.4. Autoinjectors Market for Multiple Sclerosis
12.5. Autoinjectors Market for Rheumatoid Arthritis
12.6. Autoinjectors Market for Migraine
12.7. Autoinjectors Market for Diabetes
12.8. Autoinjectors Market for Other Indications

13. CONCLUSION
13.1. Rising Incidence of Chronic Illnesses has Augmented the Demand for Devices that Enable Self-Medication
13.2. Given their Numerous Benefits, Autoinjectors have Emerged as Potent Drug Delivery Tools
13.3. Several Combination Products have Already been Approved and Many are Under Development
13.4. Majority of the Available Products are Disposable; However, Reusable Devices are Gradually Gaining Popularity
13.5. Although the Market is Led by the Well-Established Players, Start-Ups Continue to Spearhead the Innovation in this Field
13.6. Led by Several Growth Opportunities, the Market is Expected to Evolve at a Steady Pace over the Coming Decade

14. INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. PHC
14.3. Elcam Medical
14.4. DALI Medical Devices

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information about this report visit https://www.researchandmarkets.com/research/qbrh3p/global?w=12

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infusions and Injectables , Needles and Syringes